Clinical Trial Update: Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction [NA]

View source ↗

Summary

Clinical trial evaluating stereotactic MRI-guided adaptive radiation therapy (SMART) in one fraction for metastatic carcinoma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma

Snippet

Sponsor: Baptist Health South Florida | Conditions: Metastatic Carcinoma | NA | Status: COMPLETED | Results posted: 2025-07-17